Page last updated: 2024-09-03

etomoxir and Adenocarcinoma

etomoxir has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, G; Li, J; Liu, J; Miao, P; Song, S; Sun, X; Zhang, T; Zhao, L; Zhao, S; Zhao, X; Zhou, X1

Other Studies

1 other study(ies) available for etomoxir and Adenocarcinoma

ArticleYear
Inhibition of lipolysis by mercaptoacetate and etomoxir specifically sensitize drug-resistant lung adenocarcinoma cell to paclitaxel.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Adenocarcinoma; Antineoplastic Agents; Carbon Dioxide; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Epoxy Compounds; Glucose; Glycolysis; Humans; Lipolysis; Lung Neoplasms; Oleic Acid; Oxidative Phosphorylation; Paclitaxel; Thioglycolates

2013
chemdatabank.com